Synlogic announces ceo aoife brennan named to pharmavoice 100

Cambridge, mass., sept. 19, 2023 (globe newswire) -- synlogic, inc. (nasdaq: sybx), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, today announced that ceo aoife brennan, m.b. ch.b., has been honored as a pharmavoice 100 winner, a list recognizing the most inspiring people in the life sciences industry.
SYBX Ratings Summary
SYBX Quant Ranking